LINC01427: A Long Intergenic Non-Protein Coding RNA (G101929663)

Target Name: LINC01427

NCBI ID: G101929663

LINC01427

Other Name(s): long intergenic non-protein coding RNA 1427 | Long intergenic non-protein coding RNA 1427

LINC01427: A Long Intergenic Non-Protein Coding RNA

LINC01427 is a long non-coding RNA (lncRNA) that has been identified in various studies as having potential involvement in various biological processes. Its unique feature is its length, which exceeds 2000 nucleotides, making it a novel type of lncRNA. Despite its length, LINC01427 has not been well characterized, and its functions and potential drug targets are still unclear.

Structure and Expression

LINC01427 is a 2018 repeat-containing exon that is located between exons -22 and -23 of the human genomic DNA. It is expressed in various tissues and cells, including the brain, heart, liver, and pancreas, and has been shown to be expressed in various disease states, such as cancer, neurodegenerative diseases, and autoimmune diseases.

Function

LINC01427 is involved in various biological processes that are crucial for human health, including cell growth, apoptosis, and inflammation. One of its well-established functions is its role in cell death, as LINC01427 has been shown to be involved in programmed cell death (apoptosis) in various tissues.

Additionally, LINC01427 has been shown to be involved in the regulation of cellular signaling pathways, including the NF-kappa pathway. NF-kappa is a well-established growth factor that plays a crucial role in cell growth, differentiation, and survival, and is involved in numerous diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Drug Targets

Given its involvement in various biological processes, LINC01427 is a promising drug target. Several studies have suggested that LINC01427 may be a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One potential mechanism by which LINC01427 could be targeted is its involvement in cell signaling pathways, particularly the NF-kappa pathway. Small interfering RNA (siRNA) screens have identified several potential siRNA targets for LINC01427, including genes involved in cell signaling pathways, such as NF-kappa, NF-kappa-B, and SMAD.

Another potential mechanism by which LINC01427 could be targeted is its role in cell death. LINC01427 has been shown to be involved in programmed cell death (apoptosis), and therapeutic approaches that target apoptosis pathways, such as drugs that induce apoptosis, may be effective in targeting LINC01427.

Conclusion

LINC01427 is a long non-coding RNA that has been identified in various studies as having potential involvement in various biological processes. Its unique feature is its length, which makes it a novel type of lncRNA. Despite its length, LINC01427 has not been well characterized, and its functions and potential drug targets are still unclear. Further studies are needed to fully understand its role in various biological processes and its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 1427

The "LINC01427 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01427 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets